SAFETY, PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATION OF HM10460A WHEN ADMINISTERED SUBCUTANEOUSLY TO HEALTHY KOREAN VOLUNTEERS.

被引：0
|
作者：
Ahn, L. [1 ]
Shin, K. H. [1 ]
Lee, S. [1 ]
Lim, K. S. [1 ]
Yu, K. S. [1 ]
Jang, I. J. [1 ]
Shin, S. G. [1 ]
机构：
[1] Seoul Natl Univ Coll Med & Hosp, Dept Clin Pharmacol & Therapeut, Seoul, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2012年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S70 / S70
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetic and Pharmacodynamic Properties of a New Long-Acting Granulocyte Colony-Stimulating Factor (HM10460A) in Healthy Volunteers
    Kwang-Hee Shin
    Tae-Eun Kim
    Kyoung Soo Lim
    Seo-Hyun Yoon
    Joo-Youn Cho
    Sei-Eun Kim
    Kyung-Mi Park
    Sang-Goo Shin
    In-Jin Jang
    Kyung-Sang Yu
    BioDrugs, 2013, 27 : 149 - 158
  • [2] Pharmacokinetic and Pharmacodynamic Properties of a New Long-Acting Granulocyte Colony-Stimulating Factor (HM10460A) in Healthy Volunteers
    Shin, Kwang-Hee
    Kim, Tae-Eun
    Lim, Kyoung Soo
    Yoon, Seo-Hyun
    Cho, Joo-Youn
    Kim, Sei-Eun
    Park, Kyung-Mi
    Shin, Sang-Goo
    Jang, In-Jin
    Yu, Kyung-Sang
    BIODRUGS, 2013, 27 (02) : 149 - 158
  • [3] Population Pharmacokinetic and Pharmacodynamic Analysis of Belimumab Administered Subcutaneously in Healthy Volunteers and Patients with Systemic Lupus Erythematosus
    Struemper, Herbert
    Thapar, Mita
    Roth, David
    CLINICAL PHARMACOKINETICS, 2018, 57 (06) : 717 - 728
  • [4] Population Pharmacokinetic and Pharmacodynamic Analysis of Belimumab Administered Subcutaneously in Healthy Volunteers and Patients with Systemic Lupus Erythematosus
    Herbert Struemper
    Mita Thapar
    David Roth
    Clinical Pharmacokinetics, 2018, 57 : 717 - 728
  • [5] Pharmacokinetic and pharmacodynamic profile of the CCKA antagonist tarazepide in healthy volunteers.
    de Vries, MH
    Van den Broeck, P
    UdodeHaes, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 122 - 122
  • [6] Pharmacokinetic/pharmacodynamic (PK/PD) modeling of captopril in healthy volunteers.
    Yi, SY
    Bae, KS
    Lim, HS
    Cho, JY
    Yu, KS
    Jang, IJ
    Shin, SG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P74 - P74
  • [7] PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATION OF THE 2ND-GENERATION CALCIMIMETIC AGENT, KRN1493 IN HEALTHY KOREAN VOLUNTEERS.
    Lee, S.
    Kim, J. W.
    Gu, N. Y.
    Takama, H.
    Matsunaga, Y.
    Nakashima, D.
    Nishi, N.
    Jang, I. J.
    Shin, S. G.
    Yu, K. S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S26 - S26
  • [8] The effect of morphine in combination with ethanol on safety, pharmacodynamic (PD) and pharmacokinetic (PK) measures in healthy volunteers.
    Sokolowska, M.
    Sun, S.
    Johnson, F.
    Schuller, R.
    Stauffer, J.
    Romach, M.
    Sellers, E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S67 - S67
  • [9] PHARMACOKINETIC CHARACTERISTICS AND SAFETY OF β-LAPACHONE IN HEALTHY MALE VOLUNTEERS.
    Seong, S.
    Kang, W.
    Lee, J.
    Ohk, B.
    Kim, B.
    Gwon, M.
    Kim, H.
    Lee, H.
    Lee, I.
    Yoon, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S89 - S89
  • [10] Pharmacokinetic-Pharmacodynamic Modelling of Opioids in Healthy Human Volunteers. A MiniReview
    Lorenzini, Kuntheavy Ing
    Daali, Youssef
    Dayer, Pierre
    Desmeules, Jules
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 110 (03) : 219 - 226
12345